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Oral diseases, including dental caries and periodontitis, are among the most prevalent
diseases worldwide and develop as a consequence of a microbial dysbiosis. Several
bacterial strains are being tested as potential oral health-promoting organisms, but
usually they are species isolated from niches other than the site where they must exert
its probiotic action, typically from fecal samples. We hypothesize that oral inhabitants
associated to health conditions will be more effective than traditional, gut-associated
probiotic species in key aspects such as colonization of the oral site where disease takes
place or the possession of oral health promoting functions, as well as more practical
issues like safety and toxicity, and establishing proper doses for administration. As an
example of these active colonizers, we describe the case of Streptococcus dentisani, a
new streptococcal species isolated from dental plaque of caries-free individuals. We
have detected it in 98% of dental plaque samples from healthy individuals and, as
expected, it does not produce any toxic secondary metabolite and does not survive
a simulated stomach digestion, preventing potential secondary effects. Besides, this
species has a double probiotic action, as it inhibits the growth of major oral pathogens
through the production of bacteriocins, and also buffers acidic pH (the primary cause of
dental caries) through an arginolytic pathway. We propose the use of S. dentisani as a
promising probiotic against tooth decay.
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INTRODUCTION
Oral diseases such as dental caries (tooth decay) and periodontitis (gum disease) are caused by
microorganisms. However, they are currently not considered infectious diseases in classical terms
because their etiology is clearly polymicrobial (Fejerskov, 2004; Simón-Soro and Mira, 2015), and
because the pathogenic bacteria involved are also found at lower proportions in healthy individuals
(Hajishengallis and Lamont, 2012; Camelo-Castillo et al., 2015). Thus, it has been pointed out
that antimicrobial strategies may not be effective against oral diseases, and new preventive or
therapeutic approaches based on restoring the microbial ecological balance in the oral cavity have
been proposed (Marsh, 2015; Marsh et al., 2015). Those new preventive measures could include the
use of prebiotic compounds to promote the growth of health-associated bacteria (Santarpia et al.,
2014), or the application of probiotic bacteria with beneficial features (Saha et al., 2012). In the
case of dental caries, health-associated microbial communities have been identified using omics
Frontiers in Microbiology | www.frontiersin.org 1 March 2017 | Volume 8 | Article 379
fmicb-08-00379 March 8, 2017 Time: 16:13 # 2
López-López et al. Streptococcus dentisani Double Beneficial Effect
approaches (Zaura et al., 2009; Belda-Ferre et al., 2011; Alcaraz
et al., 2012), and therefore culturing those microorganisms could
provide potential beneficial bacteria to prevent oral diseases.
However, due to the greater development of probiotics in gut
pathologies, and the strong safety evidence accumulated for gut
bacteria, many microorganisms isolated from human or animal
fecal samples with beneficial properties are being developed as
potential probiotics to promote oral health. These often include
strains of lactobacilli and bifidobacteria, which had previously
been shown to have inmunomodulatory, anti-inflammatory and
anti-bacterial properties in different in vitro studies and also
in clinical trials (see Table 1; Reid et al., 2011; Cagetti et al.,
2013). However, the use of many of these strains in oral diseases
like dental caries can be problematic because both Lactobacillus
and Bifidobacterium species have been shown to be acidogenic
and to be involved in tooth decay (Badet and Thebaud, 2008;
Mantzourani et al., 2009a). Even if weak acidogenic strains are
selected, the capacity of gut bacteria to colonize the oral niche and
to produce anti-caries effects has still to be demonstrated, and the
use of gut probiotics in the oral cavity has been criticized. For
instance, when the strain Lactobacillus salivarius W24 was tested
in an in vitro oral biofilm model, it was shown that this strain
further lowered the pH and affected the compositional stability
of oral communities (Pham et al., 2009). Thus, the identification
of novel strains isolated from the oral cavity itself could be
instrumental for the development of efficient probiotics applied
to oral health.
In the current manuscript, we describe the potential probiotic
features of the new species Streptococcus dentisani that we
recently isolated from the dental plaque of caries-free individuals
(Camelo-Castillo et al., 2014). There are currently six isolates
for which the genome sequence is available and that robust
phylogenomic analysis include within the dentisani cluster
(Jensen et al., 2016). This cluster forms part of the S. oralis clade
and differs from the S. oralis and S. tigurinus clusters mainly
in their ability to hydrolyze arginine (Jensen et al., 2016). In
this manuscript, we study strains 7746 and 7747T, which were
isolated from two different individuals and that were shown to be
different by comparison of their genomes (Camelo-Castillo et al.,
2014). We describe their ability to inhibit the growth of caries-
producing bacteria, as Streptococcus mutans and Streptococcus
sobrinus, and to buffer extracellular acidic pH, which is the
underlying cause of tooth decay. In addition, we show that, being
a commensal species in the oral cavity of healthy individuals, their
safety features are robust and the appropriate dose for probiotic
treatment can be easily determined experimentally.
MATERIALS AND METHODS
Inhibition Assays with S. dentisani
Supernatants
Inhibition experiments against cariogenic bacteria were carried
out with concentrated supernatants of well grown cultures of
S. dentisani 7746 and 7747 (stationary phase). In order to obtain
5 ml of the concentrated supernatants, single colonies of each
S. dentisani strain were inoculated into 50 ml of brain hearth
infusion broth (BHI, Biolife) and incubated aerobically at 37◦C
without agitation during 48 h, or until they reached an optical
density of around 1.5 at 610 nm (O.D. 610). After the incubation
period, the cultures were centrifuged at 4000 rpm 10 min and
the pellets discarded. The obtained supernatants were filtered
throughout 0.2 µm pore-size filters (Millipore) and ten-fold
concentrated by rotary evaporation on a RV 10 digital device
(VWR) with the following settings: heating bath at 40◦C, 70
rpm of rotation, 100 mbar of pressure, and 30 min of operating
time. The resulting 5 ml of concentrated supernatants were
filtered throughout 0.2µm pore-size filters (Millipore) and stored
at –20◦C until use.
The inhibitory activity of the supernatants was determined
by monitoring the growth of S. mutans ATCC 25175 and
S. sobrinus CECT 4034 in the presence/absence of the potential
inhibitor by means of optical density measurements. Pre-inocula
of S. mutans and S. sobrinus were obtained by inoculating
a single colony of each strain in 10 ml of BHI liquid
medium and incubated aerobically overnight at 37◦C without
agitation. The O.D. 610 of the pre-inocula was measured in
a spectrophotometer (BioPhotometer, Eppendorf) and diluted
with BHI liquid medium to obtain an optical density of 0.1.
To assess the inhibitory effect of S. dentisani on the growth of
S. mutans and S. sobrinus, 160 µl of the bacterial suspensions
were mixed with 40 µl of the concentrated supernatants and
loaded by triplicate into a Nunc Microwell 96-well microplate by
triplicate. As controls, 160 µl of the bacterial suspensions were
mixed with 40 µl of 10-fold concentrated BHI and loaded by
triplicate into the 96-well microplate. The microplate was loaded
into a microplate reader (Infinite 200 PRO, Tecan) and incubated
at 37◦C during 24 h. The O.D. 610 of each inoculated well was
measured every 30 min during the incubation time.
To determine the active size fraction, the concentrated
supernatant was size-fractionated by sequential filtering
throughout 10 KDa and 3 KDa filters (Amicon), following the
manufacturer’s recommendations. By this way, we obtained
three size fractions (>10 KDa, 3–10 KDa, and <3KDa) that
were tested by triplicate against S. mutans cultures by the same
methodology explained above. To confirm the peptidic nature
of the inhibitory compounds and discard that the inhibition
was produced by hydrogen peroxide we proceed as described
in Zhu and Kreth (2012). Briefly, S. dentisani was grown on a
BHI plate for 24 h and peroxidase (40 µg), peptidase (64 µg), or
phosphate-buffered saline were applied beside each colony for
10 min before the other species were inoculated at the same spot.
S. mutans and S. sanguinis were used as controls of proteinaceus
inhibitory substance and H2O2, respectively.
Besides, we used scanning electron microscopy (SEM) to
directly observe the effect of the S. dentisani supernatants on the
three type strains S. mutans ATCC 25175, Prevotella intermedia
NCTC 13070, and Fusobacterium nucleatum DSMZ 20482 cells.
Briefly, 160 µl of the bacterial cultures in exponential phase
(O.D. 610 = 0.6) were mixed with 40 µl of the concentrated
supernatant and incubated for 30, 60, and 90 min at 37◦C.
After the incubation period, the suspensions were centrifuged
at 4000 rpm 10 min and the supernatant discarded. The pellets
were fixed in 2.5% paraformaldehyde and 0.5% glutaraldehyde,
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TABLE 1 | Bacteria tested in clinical trials as oral care probiotics.
Strain Origin Brand Disease Reference1
Lactobacillus rhamnosus GG Human intestinal tract Caries Aminabadi et al., 2011
Lactobacillus rhamnosus LB21 Human intestinal tract Caries Stecksén-Blicks et al., 2009
Lactobacillus reuteri 55730 + PTA
5289
Woman breast milk ProdentisTM Ginvival health, plaque
reduction and caries
Krasse et al., 2006; Caglar
et al., 2008a
Lactobacillus brevis CD2 Dairy products Inersan R© Periodontal disease and
caries
Riccia et al., 2007; Campus
et al., 2014
Lactobacillus paracasei SD1 Human oral cavity Caries Ritthagol et al., 2014
Bifidobacterium animalis DN-173 010 Dairy products ACTIVIA R© Caries Caglar et al., 2005
Bifidobacterium animalis subsp. lactis
BB-12 R©
Dairy cultures BB-12 R© Caries Caglar et al., 2008b
Streptococcus salivarius M18 Saliva of a healthy child BLIS M18 R© Plaque reduction Burton et al., 2013
Lactobacillus salivarius WB21 Mammalian digestive tract Gingival health, periodontal
disease, halitosis and caries
Shimauchi et al., 2008;
Mayanagi et al., 2009; Iwamoto
et al., 2010; Suzuki et al., 2014
Streptococcus oralis KJ3 R©,
Streptococcus uberis KJ2 R© and
Streptococcus rattus JH145 R©
Healthy mouths ProBiora(3) R© Caries, periodontal disease
and halitosis
Zahradnik et al., 2009
Weissella cibaria CMU, CMS-1, CMS-2
and CMS-3
Children’s saliva Halitosis and plaque
reduction
Kang et al., 2006a,b
Lactobacillus reuteri DSM 17938 +
PTA 5289
Human saliva BioGaia ProDentis Halitosis Keller et al., 2012
Lactobacillus plantarum 7481 and
Lactobacillus brevis 7480
Children’s saliva AB:Dentis R© Halitosis and gingivitis WO 2012022773 A1∗
Streptococcus salivarius K12 Children’s saliva BLIS K12 R© Halitosis Burton et al., 2006
Lactobacillus acidophilus NK1 +
100ash + K3III24
Human intestinal tract Acilact (solely Russia) Periodontal disease Pozharitskaia et al., 1994
Bifidobacterium bifidum N1 and
Lactobacillus acidophilus NK1
Human intestinal tract Bifidumbacterin + Acilact
(solely Russia)
Periodontal disease Grudianov et al., 2002
Lactobacillus casei 37 Human intestinal tract Periodontal disease Volozhin et al., 2004
Lactobacillus paracasei GMNL-33
(ADP-1)
Human oral cavity Dental-LacTM Periodontal disease Chuang et al., 2011
Lactobacillus salivarius TI 2711 (LS 1) Human saliva Periodontal disease Matsuoka et al., 2006
Lactobacillus rhamnosus GG (53103) +
LC705
Human intestinal tract Oral candidasis Hatakka et al., 2007
1Reference = Publication with results of clinical trial; ∗Patent number.
washed three times with PBS buffer and exposed to 1% osmium
tetroxide in PBS buffer for 1 h. The samples were rinsed
with PBS buffer three more times and then moved through a
gradual process of dehydration, starting with 30% ethanol and
ending with absolute ethanol (multiple rinse steps at each 30,
50, 70, 80, 90, and 100% ethanol). Finally, the samples were
mounted on scanning electron micrograph stubs, sputter coated
with gold, and viewed on a JEOL JSM 840 scanning electron
microscope.
pH Range of Growth and Resistance of
S. dentisani to the Digestive Process
To know the optimal and pH growth range of S. dentisani
strains 7746 and 7747 we prepared BHI broth at different pHs
(4.7, 5.5, 6, 6.5, 7, and 7.5) by adding NaOH 10 N or HCl
10 N to the commercial medium (Biolife). Pre-inocula were
obtained as explained above. Two-hundred microliters of the
BHI broths at different pHs were inoculated by triplicate with
20 µl of the inocula into a Nunc Microwell 96-well microplate.
The O.D. 610 of each inoculated well was measured every 2 h
and plotted versus the time of incubation to obtain the growth
curves.
To evaluate the resistance of S. dentisani to the digestive
process, the viability of the strains 7746 and 7747 was checked
after a treatment with the salivary enzyme alpha amylase,
followed by digestion with gastric enzymes under progressive
acidic conditions to simulate digestion, following the protocol
described in Khalf et al. (2010) and Martínez et al. (2011).
The assays were performed in an in vitro model stomach (or
dynamic digester) by the external services of the Food Industry
Research Association AINIA (Valencia, Spain). Each strain was
tested by duplicate whereas the control was assayed once. Colony
forming units (CFU) counts were obtained in BHI agar before
any treatment (reference cultures), after the chewing step, and
during the gastric digestion at three different times (30, 60,
and 120 min). The plates were incubated at 37◦C during 24–
48 h. As the medium used for CFU counts was not selective for
S. dentisani, the same assay was made without inoculation and
used as blank to discount any contamination, obtaining 0 CFUs
in this control.
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Growth of S. dentisani in an Arginine
Enriched Medium
Streptococcus dentisani 7746 was grown in 300 ml of BHI medium
amended with 5 g/l of L-arginine monohydrochloride 98% (Alfa-
Aesar). The pre-inoculum was obtained by inoculating a single
colony of the strain in 10 ml of BHI broth and incubating
overnight at 37◦C without agitation. Inoculation was made with
the volume required to obtain an initial O.D. 610 of 0.02. For
comparison, the same volume was used to inoculate 300 ml of
BHI without arginine. In both conditions the initial pH was
set at 7.3. The cultures were incubated at 37◦C during 24 h
and aliquots of 1 ml were taken every hour for measuring
the pH and the O.D. 610. Both conditions were assayed by
triplicate.
Prevalence of S. dentisani and Other
Oral Probiotics in the Dental Plaque of
Healthy Individuals
To assess the prevalence of S. dentisani in the dental plaque
of healthy individuals we compared the genomic sequences
of the S. dentisani strains 7746 and 7747 (1.98 and 1.74 Mb,
respectively) against 118 metagenomes of the dental plaque of
healthy individuals available at The Human Microbiome Project
Consortium (HMP, Turnbaugh et al., 2007). The metagenomic
reads were mapped against the sequenced reference genomes
using the NUCmer and PROmer v3.06 alignment algorithms
(Kurtz et al., 2004) with the default parameters, following the
methodology of Belda-Ferre et al. (2011). We considered that
S. dentisani was present in a sample if at least 20 sequences
>100 bp of the metagenome showed a similarity equal to or
higher than 99% with the sequenced genomes. For comparison,
the same approach was used to analyze the prevalence of
S. salivarius in dental plaque.
The presence of the genus Lactobacillus in different parts of the
oral cavity was performed by the analysis of the oral 16S rDNA
sequences deposited in the Human Microbiome Project database
in year 20141. The niches analyzed were the keratinized gingiva,
buccal mucosa, hard palate, palatine tonsils, saliva, supra- and
subgingival plaque, and tongue dorsum. The analyses were
carried out with a total of 4.3 × 108 sequences. The taxonomic
affiliation was performed using the Megablast tool implemented
in the NCBI against the SILVA ribosomal database2, with the
following parameters: e value <1e–10, percent identity >97%,
alignment length >350 bp.
Quantification of S. dentisani in the
Dental Plaque of Healthy Individuals
Two healthy volunteers, named MG01 and MG02, were
selected for sampling. They were males aged 20–30 years,
non-smokers, with 28 teeth excluding third molars, with good
dental and periodontal health: in both, absence of caries
(non-cavitated level), DMF = 0, OHI = 0, GI = 1, and
CPI= 1 (following nomenclature by World Health Organization
1http://hmpdacc.org
2http://www.arb-silva.de
[WHO], 1997). They had not been treated with antibiotics in
the 6 months prior to the study nor presented antecedents
of routine use of oral antiseptics. The two donors signed
a written informed consent and the sampling procedure
was approved by the Ethics Committee from the DGSP-
CSISP (Valencian Health Authority), with reference 10/11/2009.
Supragingival and subgingival dental plaque samples were
taken from vestibular (buccal) and lingual (palatine) surfaces
of 28 teeth in each volunteer. Streptococcus dentisani was
quantified in individual free surfaces of each tooth type
(incisor, canine, premolar, and molar) from one quadrant and
the absolute numbers calculated by multiplying the obtained
value by the number of each tooth type in the mouth. The
same procedure was followed for the total bacterial content
quantification.
Dental plaque samples were resuspended in 100 µl of PBS
buffer and DNA was extracted with the MagnaPure LC JE379
instrument and the MagnaPure LC DNA Isolation Kit (Roche).
The quantification of the DNA was done with the Quant-iT
PicoGreen dsDNA Assay Kit (Invitrogen), and real-time PCR was
performed in a LightCycler 480 System with the LightCycler 480
SYBR Green I Master Mix (Roche). In every step, we followed the
manufacturer’s recommendations.
The specific primers used for the quantification of
S. dentisani were designed for this study and targeted the
genes for the carbamate kinase (arcC): CkSdF 5′-GTAAC
CAACCGCCCAGAAGG-3′ and CkSdR 5′-CCGCTTTCGGA
CTCGATCA-3′; and the ORF540: Orf540F (5′-ATGTTCA
TCGGCTTGACAGGCTT-3′) and Orf540R (5′- TAAGCAA
GCATAGAACCGCGCC-3′). Primers specificity was predicted
in silico by the primerBLAST tool implemented in the NCBI3
and confirmed by absence of amplification by qPCR with 5 ng/µl
DNA from S. mutans, S. sobrinus, S. sanguinis, S. salivarius,
S. mitis, S. pneumoniae, S. infantis, and S. oralis. The specificity
of the primers was also checked by scrutinizing the melting
profiles after every assay. Primers for the Ck gene did not
amplify any of the tested streptococcal species. Primers for the
ORF540 amplified only the DNA of S. pneumoniae, which is a
rare inhabitant of dental plaque. Amplification was performed
in a 20 µl final volume containing 1 µl of template DNA
(at concentrations 5–22 ng/µl), 10 µl of the LightCycler 480
SYBR Green I Master Mix, 0.4 µl of each primer, and 7.2 µl of
nuclease-free water. The thermocycling protocol used was as
follows: an initial step of 95◦C for 5 min, and 40 cycles of 10 s at
95◦C, 20 s at 65◦C, and 25 s at 72◦C. All the quantifications were
made by duplicate.
The concentration of S. dentisani in each sample was
calculated by comparison with the Cq values obtained from
a standard curve. This was generated using serial 10-fold
dilutions of DNA extracted from 2 × 107 CFUs/ml (counted
by serial dilutions in agar plates). Finally, the Cq values
obtained with the plaque samples were replaced in the standard
equation and expressed in absolute numbers per tooth type
analyzed.
3www.ncbi.nlm.nih.gov/tools/primer-blast
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RESULTS
Inhibitory Activity of the S. dentisani
Supernatants
As shown in Figure 1A, the addition of the S. dentisani 7746
concentrated supernatant produced a marked inhibitory effect
on the growth of both S. mutans and S. sobrinus, as compared
to the curves obtained when only concentrated BHI was added.
Similarly, the concentrated supernatant completely inhibited
the growth of other S. mutans strains (strains OMZ175 and
ATCC 700610, data not shown). Regarding the curves obtained
with the different size fractions, the <3 KDa fraction retained
the inhibitory activity when tested against S. mutans ATCC
25175, while the 3–10 KDa and >10 KDa fractions did not
(Figure 1B). The last two even enhanced the growth of S. mutans,
probably due to a higher availability of nutrients coming
from the concentrated culture medium and/or the S. dentisani
metabolism. The same results were obtained with strain 7747
(data not shown).
Microscopy visualizations revealed that after 30 min of
incubation with concentrated supernatants of S. dentisani, the
cells of S. mutans, F. nucleatum, and P. intermedia were clearly
affected, showing pores in the surface of the cells (S. mutans),
changes in the cell walls’ structure (P. intermedia) and cell lysis
(F. nucleatum) (Figures 2A–C).
Proteinase treatment of the supernatant provoked the absence
of growth inhibition when tested against S. mutans, while
the peroxidase treatment did not affect the inhibitory activity
(Figure 3). Taken together, the results indicated that the
inhibition is not due to the production of hydrogen peroxide,
and supports the idea that S. dentisani inhibit oral pathogenic
bacteria by the production of inhibitors of peptidic nature, such
as bacteriocin-like peptides.
pH Tolerance and Resistance of
S. dentisani to the Digestive Process
Streptococcus dentisani was tested for its ability to grow at
different pHs. The growth curves obtained showed that both
strains displayed a very similar behavior, with an optimal growth
pH close to 7 (Supplementary Figures S1A,B). It is noteworthy
that they were able to grow at pH values between 6 and 7.5 but
not between 4.7 and 5.5, indicating that S. dentisani can endure
moderately acidic conditions but is not an acidophilic organism.
Surprisingly, the growth of both strains at pH 6 was better than at
6.5, suggesting the activation of a buffering metabolic pathway
at pH values around 6 (see Section “pH Buffering Capacity of
S. dentisani” below).
Regarding the simulated digestive process, and as expected
from the pH curves obtained before, S. dentisani was not able
to maintain the initial viability during digestion simulations. As
starting values of viability we obtained 6.5 × 108 and 3.9 × 108
CFUs/ml for the strains 7746 and 7747, respectively. After the
chewing simulation with salivary enzymes these values decreased
in only two to three orders of magnitude, showing that both
strains could remain in the mouth at high levels after chewing,
whereas the gastric digestion strongly inhibited their growth,
FIGURE 1 | (A) Growth curves of the cariogenic bacteria Streptococcus
mutans ATCC 25175 (squares) and S. sobrinus CECT 4034 (circles) in the
presence (dotted lines) and absence (solid lines) of concentrated supernatant
of S. dentisani strain 7746. (B) Growth curves of S. mutans ATCC 25175 in
the presence of different size fractions of the 10× concentrated supernatant
of S. dentisani 7746. Circles correspond to the fraction >10 KDa, squares to
the 3–10 KDa fraction, and triangles to the fraction <3 KDa. For comparisons,
S. mutans was grown in the presence of 10x concentrated BHI medium
(dotted line). Means ± SD from three independent replicates are plotted.
even after the first step of the simulation (30 min, see Table 2).
As neither strain of S. dentisani survived the gastric process, the
simulation of an intestinal digestion was not performed.
pH Buffering Capacity of S. dentisani
Figure 4 depict the growth curves obtained by triplicate when
S. dentisani 7746 was grown in presence/absence of arginine.
During the initial 6 h of incubation, the growth seemed to be
fueled by the sugars present in the BHI medium, as the growth
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FIGURE 2 | Scanning electron microscopy (SEM) of three oral pathogens before (left) and after (right) a 30-min treatment with 10-fold concentrated
supernatant of S. dentisani strain 7746. (A) Streptococcus mutans (pores are pointed with arrows). (B) Fusobacterium nucleatum. (C) Prevotella intermedia.
curves were identical in both conditions (with and without
arginine), and the culture pH dropped from 7.3 to about 6.2. Soon
after completion of this first phase, in the cultures containing
arginine the pH starts to rise, reaching almost the initial pH
value 12 h after inoculation. Contrarily, in the medium without
arginine the pH continuously decreased to reach a value of
about 6.2. In both conditions the O.D. 610 measurements were
similar, with a maximum value of around 1.3 after 12 h of
incubation.
The analysis of the genome of S. dentisani showed that strains
7746 and 7747T contain the key genes of the arginine deiminase
system: arcA (arginine deiminase, locus tag HK29_RS02275),
arcC (carbamate kinase, locus tag HK29_RS02285), and arcB
(ornithine carbamoyltransferase, locus tag HK29_RS02280),
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FIGURE 3 | Inhibition of S. mutans by S. dentisani in the presence of peroxidase and proteinase. The tests were performed with S. dentisani strains 7746
and 7747, treating with the enzymes the spots where S. mutans would later be grown. The controls on the left panel show the inhibition without treatment.
FIGURE 4 | Growth curves of S. dentisani strain 7746 in a medium with (triangles) and without (circles) the addition of 5 g/l of arginine. The mean ± SD
of O.D. 610 (solid lines) and pH of the culture (dotted lines) from three replicates are depicted.
involved in the ammonia generation through arginine
metabolism, a mechanism that releases ammonnia extracellularly
producing the alkalinization of the environment (Liu et al., 2008,
2012).
Prevalence of S. dentisani in the Dental
Plaque of Healthy Individuals
The recruitment analyses showed that sequences of S. dentisani
were present in most of the analyzed metagenomes (direct,
whole-sequenced DNA coming from dental plaques of healthy
individuals at the Human Microbiome Project). At least 20
metagenomic sequences>100 bp were found to have a similarity
≥99% compared with the 7746 genome in 116 out of 118
individuals, and in the strain 7747 this threshold was fulfilled
in all 118 individuals. Contrarily, the species S. salivarius that
has been proposed as a probiotic agent against caries was only
detected in three of these metagenomes, in agreement with this
species inhabiting mucosal surfaces and not the hard tissues.
In addition, we have analyzed the Lactobacillus 16S rRNA gene
sequences from oral samples contained in the HMP database,
as this genus contains species commonly used as oral probiotics
(namely L. acidophilus, L. reuteri, and L. rhamnosus). The
results showed that Lactobacillus spp. is present in very low
numbers in the oral cavity, accounting for less than 0.05% of
the bacterial genera in the buccal mucosa, hard palate, palatine
tonsils, saliva, tongue, and supragingival plaque. The highest
numbers of Lactobacillus 16S rDNA sequences were obtained
in the subgingival plaque, but even here this genus accounted
for only 0.94% of the total bacterial population. We analyzed in
the same oral niches the prevalence of the genus Streptococcus,
which was found to be present at very high numbers in the
keratinized gingiva, buccal mucosa, hard palatine, palatine tonsil,
tongue dorsum, and saliva (59.5, 58.8, 54, 27.1, 26.8, and 19.7 per
cent of the total bacterial members, respectively). Furthermore,
the percentage of the genus Streptococcus in the subgingival and
supragingival plaques was high (18.8 and 20.2%, respectively).
Overall, the results showed that the genus Streptococcus is much
more abundant than Lactobacillus in every analyzed oral niche,
and particularly in those directly affected by the cariogenic
processes, being Streptococcus between 20 and 600 times more
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TABLE 2 | Viability, expressed in CFU/ml, of the two strains of S. dentisani after the chewing and gastric digestion processes (G.D.) at three different
times.
Strain Starting culture Chewing pH 6.9 G.D. 30 min pH 3 G.D. 60 min pH 2.1 G.D. 120 min pH 1.7
S. dentisani 7746 6.5 × 108 ± 3.05 × 108 5.3 × 106 ± 2.8 × 108 <10 <10 <10
S. dentisani 7747 3.9 × 108 ± 4 × 107 1 × 106 ± 9.8 × 105 <10 <10 <10
The values shown are the mean of two independent replicates and the standard deviation is specified.
TABLE 3 | Total cell counts of S. dentisani on supragingival dental plaque in the vestibular (V) and lingual (L) parts of different tooth types in two
caries-free individuals (MG01 and MG02).
Incisor Canine Premolar Molar
MG01 (V)
(L)
2.1× 105/2.8× 104
2.8× 105/2.7× 104
4.7× 105/7.9× 104
1.4× 105/4.1× 105
2.9× 105/3.46× 104
4.6× 105/9.8× 106
3.1× 105/3.1× 104
4.3× 105/6.9× 104
MG02 (V)
(L)
5.5× 102/7.5× 103
3.4× 104/5.1× 104
2.7× 103/4.4× 103
2.8× 104/5.9× 103
1.2× 103/1.3× 104
7.1× 104/5.0× 105
2.5× 104/4.5× 104
4.7× 104/1.7× 107
Data show the estimates of bacterial numbers obtained by qPCR with two different sets of S. dentisani-specific primers (orf540/CK).
abundant than Lactobacillus in the subgingival and supragingival
plaque, respectively.
Quantification of S. dentisani in the
Dental Plaque of Healthy Individuals by
q-PCR
The absolute numbers of S. dentisani cells were obtained for the
teeth’s free surfaces of two healthy volunteers by the use of two set
of S. dentisani-specific primers, which provided similar estimates
(Table 3). The results showed that both individuals contain very
similar values of abundance of S. dentisani (1.04 × 107 and
3.14 × 107 cells for MG01 and MG02, respectively, as estimated
by the ORF540 primers; 4.46 × 107 and 6.94 × 107 cells for
MG01 and MG02, as estimated by the carbamate kinase primers).
However, although the calculated S. dentisani numbers in the
mouth of both individuals was highly similar, its distribution
was very different. As shown in Table 3, MG01 did not show
important differences in the amounts of S. dentisani between
tooth types nor between the lingual and vestibular surfaces.
Patient MG02 however, had a more heterogeneous distribution,
with higher proportions of S. dentisani in premolars and molars,
and on the lingual surfaces of every tooth type.
DISCUSSION
Dental caries is considered the most prevalent disease worldwide,
with up to 80% of the human population being affected at
some point during their lives (Petersen and Lennon, 2004).
There are however no efficient means to prevent it, as the
polymicrobial nature of the infection and its complex etiology
make passive and active immunization strategies (e.g., a caries
vaccine) ineffective (Fejerskov, 2004; Simón-Soro and Mira,
2015). Thus, new strategies directed towards the re-establishment
of the natural balance in the oral microbiome like the use of
pre- and probiotics have been proposed (Marsh et al., 2015).
However, as shown in Table 1, most of the probiotics proposed
to promote oral health are bacteria isolated from environments
other than the oral cavity, usually the human gut (Cagetti et al.,
2013). In addition, the most commonly used probiotic bacteria
to treat dental caries are lactobacilli, due to their well-proven
safety characteristics. However, the use of non-oral bacteria
may prevent efficient colonization of the oral niche, which is
a vital and desirable feature of probiotics. This is supported
by the low frequencies of lactobacilli detected in tooth tissues
by molecular methods, as reported in the current manuscript.
In addition, lactobacilli are important acid-producers and long
known to be associated to dental caries lesions (Badet and
Thebaud, 2008; Plonka et al., 2012), as well as bifidobacteria
(Mantzourani et al., 2009b; Beighton et al., 2010), which are also
common oral probiotics. This can be the reason why in vitro
experiments with these bacteria, even if low-acid producing
strains are selected, may result in pH acidification (Pham et al.,
2009). These results underline the need to use potential probiotics
from the oral cavity, and therefore the isolation of a bacteriocin-
producing probiotic Streptococcus salivarius which inhibited the
cariogenic agent S. mutans was promising (Wu et al., 2015).
However, the comparison of the S. salivarius genome against
a high number of metagenomes from supragingival plaque
presented in the current manuscript reveals its absence in
the tooth, in agreement with its soft-tissues-associated nature.
Streptococcus salivarius is a typical inhabitant of the buccal
epithelium, tongue, and dorsal epithelium (Bowden et al., 1979;
Power et al., 2008) and comprises an important part of the
total cultivable flora on the soft tissues of the mouth (Wilson,
2005). Probably for this reason, it has been proposed as a
probiotic for the pharyngeal mucosa (Guglielmetti et al., 2010)
but its inability to colonize the tooth surface may hamper its
potential as an anti-caries probiotic. The high heterogeneity
of environments in the mouth and the resulting adaptation
of microorganisms to those specific microniches (Simon-Soro
et al., 2013) underscores the importance of selecting oral bacteria
adapted to live in hard tissues as probiotics against dental
caries to guarantee a proper colonization. In agreement with
this view, our data show that Streptococcus dentisani, which
was isolated from supragingival dental plaque of caries-free
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FIGURE 5 | Potential buffering effect in the oral cavity due to the enrichment of the dental plaque bacterial community with Streptococcus dentisani.
When arginine is available (either as an added prebiotic or as a product of peptide degradation) and S. dentisani is established on the tooth surfaces, the pH drop
caused by the accumulation of organic acids can be buffered by the production of NH4+ through the arginolytic pathway, maintaining the pH close to neutrality (right
panel). In the absence of S. dentisani, or if present at low proportions, the buffering effect would be diminished, with the consequent acidification and enamel
damage. This would be the perfect scenario for the proliferation of acidogenic/cariogenic microorganisms (left panel).
individuals (Belda-Ferre et al., 2011; Camelo-Castillo et al., 2014),
was widespread among dental plaque samples from healthy
subjects.
Apart from dental colonization, we show that an important
probiotic feature of S. dentisani is its anti-microbial properties,
inhibiting the growth of important oral pathogens like S. mutans,
S. sobrinus, or Prevotella intermedia. In addition, the killing of
Fusobacterium nucleatum is unusual among oral probiotics and
may provide an important beneficial effect, as this organism is
responsible for a large number of co-aggregation patterns with
many oral species and is considered the main “bridge” bacteria
between early and late colonizers of dental plaque (Kolenbrander
et al., 2002). Thus, its inhibition could contribute to impede the
adhesion of pathogenic organisms that co-aggregate with this
bacterium and by doing so hamper dental plaque development,
whose maturity has been shown to considerably increase the
drop in pH after a meal (Firestone et al., 1987). In addition,
F. nucleatum itself has been associated with halitosis due to
the production of volatile sulfur compounds (Krespi et al.,
2006), and therefore its growth inhibition should be investigated
in the future as a way to diminish the severity of this
condition.
The different experiments performed in the current work
suggest a peptidic nature of the inhibitory molecules, as
the inhibitory effect was significantly reduced by proteinase
treatment but was unaffected by peroxidase, indicating that the
inhibition was not due to the production of hydrogen peroxide
as it is common in other streptococci (Zhu and Kreth, 2012).
This, together with the small size of the molecules responsible
for the inhibition (<3 KDa) and the appearance of pores in the
membrane of sensitive bacteria as identified by SEM, strongly
suggest that the inhibition is caused by bacteriocins, and future
work should be directed towards identifying and characterizing
such antimicrobial peptides.
Dental caries, as well as other oral diseases like periodontitis
or halitosis are not considered typical infectious diseases in
classical terms, as there is more than one species responsible for
their etiology, the microbial consortia causing the disease varies
considerably between individuals and even between lesions of the
same patient, and pathogenic organisms normally can be isolated
also from healthy individuals (Hajishengallis and Lamont, 2012;
Simon-Soro et al., 2014; Camelo-Castillo et al., 2015; Marsh
et al., 2015; Simón-Soro and Mira, 2015). For these reasons,
antimicrobial properties of probiotics may not be sufficient for
effectively preventing dental caries (ten Cate and Zaura, 2012)
and the ability to restore the microbial ecological balance after
pH acidification, for instance by alkali production, is a promising
probiotic feature (Huang et al., 2015). Production of ammonia
from urea or arginine by several oral bacteria has been shown
to efficiently buffer salivary pH and has been associated to a
reduction in caries risk (Reyes et al., 2014; Moncada et al., 2015).
The analysis of the genome of Streptococcus dentisani revealed
all genes from the arginolytic pathway, including the arginine
deiminase and the carbamate kinase, a feature which appears
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to be common to all members of the cluster (Jensen et al.,
2016). In addition, the agmatine deiminase gene, involved in
the production of ammonia (Liu et al., 2012) was also present
in both analyzed strains. In agreement with this, our data show
that S. dentisani was able to efficiently buffer extracellular pH
in the presence of arginine. Arginine is present in saliva in
variable concentrations and it has also been added as a prebiotic
to toothpaste, with strong clinical evidence for reducing enamel
demineralization and buffering acidic pH (Yin et al., 2013;
Santarpia et al., 2014). In addition, we have found in the genome
of S. dentisani genes encoding for different aminopeptidases that
can liberate arginine from peptides and proteins (Gonzales and
Robert-Baudouy, 1996), which could then enter the arginolytic
pathway. This is supported by the higher growth of the bacterium
at pH 6 than at pH 6.5 in standard BHI growth medium
(Supplementary Figure S1). Given that its optimal growth pH
is neutral, and that the arginolytic pathway has been shown
to be activated by low pH in other species (Liu et al., 2008),
the higher growth rates at pH 6 are probably the result of
protein degradation liberating arginine, which would allow the
production of NH4, as well as the production of ATP derived
from this metabolic route. These results also suggest that the full
activation of the arginine degradation genes occurs at pH < 6.5,
and the regulation of this pathway should be studied in the future.
In Figure 5, we have illustrated the buffering effect that could take
place in the oral cavity due to the enrichment of the dental plaque
bacterial community with S. dentisani. When acidification occurs
as a consequence of the consumption of dietary carbohydrates,
and the pH drops to values around 6, S. dentisani would be able to
activate the ADS system producing ammonia and, consequently,
buffering the pH of its close environment.
The double beneficial action of S. dentisani (i.e., anti-microbial
and anti-acid) makes it a promising probiotic bacterium. These
benefits, together with its dental colonization capacity, derive to
a big extent from its oral inhabitance. In addition, the choice of a
dental plaque species as probiotic allows the quantification of the
species in caries-free individuals, in order to use those levels as
the appropriate administration dose, instead of using the dosages
normally delivered for gut probiotics. In the current manuscript,
we have quantified S. dentisani amounts in dental plaque for
just two individuals and similar estimates for larger sample sizes
could serve to accurately determine the dosage for an appropriate
treatment.
For all these reasons, we propose the use of probiotics which
are active colonizers, that is microorganisms which inhabit the
site where the disease takes place, and that are isolated from
healthy individuals. We believe that the administration of these
organisms will maximize the chance of colonization and the
potential beneficial effects for human and animal health. In the
case of dental caries, we encourage the search of probiotic bacteria
that are normal inhabitants of the human supragingival plaque in
healthy individuals and propose the use of S. dentisani in clinical
trials to test its potential in promoting oral health.
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